Abstract
N6-methyladenosine (m6A) RNA modification impacts mRNA fate primarily via reader proteins, which dictate processes in development, stress, and disease. Yet little is known about m6A function in Saccharomyces cerevisiae, which occurs solely during early meiosis. Here, we perform a multifaceted analysis of the m6A reader protein Pho92/Mrb1. Cross-linking immunoprecipitation analysis reveals that Pho92 associates with the 3’end of meiotic mRNAs in both an m6A-dependent and independent manner. Within cells, Pho92 transitions from the nucleus to the cytoplasm, and associates with translating ribosomes. In the nucleus Pho92 associates with target loci through its interaction with transcriptional elongator Paf1C. Functionally, we show that Pho92 promotes and links protein synthesis to mRNA decay. As such, the Pho92-mediated m6A-mRNA decay is contin-gent on active translation and the CCR4-NOT complex. We propose that the m6A reader Pho92 is loaded co-transcriptionally to facilitate protein synthesis and subsequent decay of m6A modified transcripts, and thereby promotes meiosis.
Original language | English (US) |
---|---|
Article number | e84034 |
Journal | eLife |
Volume | 11 |
DOIs | |
State | Published - Nov 2022 |
Funding
We are grateful to the members of the laboratory of Folkert van Werven for fruitful discussions and critical reading of the manuscript. We thank members of Ule and Luscombe labs, specifically Julian Zagalak, Christoph Sadee, Patrick Toolan-Kerr, Igor Ruiz De Los Mozos, Paulo Gameiro, Federica Capraro, Andrew Steele and Flora Lee for sharing ideas, protocols and reagents towards the iCLIP and miCLIP experiments and analysis. We acknowledge Leon Chan, Elçin Ünal, and Martin Pool for sharing reagents and Schraga Schwartz and David Dierks for providing the m6A-seq2 data. We thank the Crick Advanced Sequencing, Proteomics, Metabolomics, Fermentation and Genomics Equipment Park Facilities for experimental support, specifically Phil East for helping with submission to GEO, James MacRae, Christoph Messner and Svend Kjaer for technical support. We also are grateful to the three reviewers for their comments and suggestions.The Vermeulen lab is part of the Oncode institute, which is partly funded by the Dutch Cancer Society (KWF). This research was funded in whole, or in part, by the Wellcome Trust (FC001203, FC010110, FC001134). For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. This work was supported by the Francis Crick Institute (FC001203, FC010110, FC001134), which receives its core funding from Cancer Research UK (FC001203, FC010110, FC001134), the UK Medical Research Council (FC001203, FC010110, FC001134), and the Wellcome Trust (FC001203, FC010110, FC001134).Wellcome Trust (FC001203) – Radhika Varier, Theodora Sideri, Zornitsa Manova, Imke Ensinck, Alice Rossi, Folkert van Werven; CRUK (FC001203) - Radhika Varier, Theodora Sideri, Zornitsa Manova, Imke Ensinck, Alice Rossi, Folkert van Werven; Medical research council (FC001203) - Radhika Varier, Theodora Sideri, Zornitsa Manova, Imke Ensinck, Alice Rossi, Folkert van Werven; Wellcome Trust (FC010110) – Charlotte Capi-tanchik and Nicholas Luscombe; CRUK (FC010110) - Charlotte Capitanchik and Nicholas Luscombe; Medical research council (FC010110) - Charlotte Capitanchik and Nicholas Luscombe; Wellcome Trust (FC001134) – Enrica Calvani and Markus Ralser; CRUK (FC001134) - Enrica Calvani and Markus Ralser; Medical research council (FC001134) - Enrica Calvani and Markus Ralser; Dutch Cancer Society (KWF) -Raghu Edupuganti and Michiel Vermeulen.The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. We also are grateful to the three reviewers for their comments and suggestions.
ASJC Scopus subject areas
- General Neuroscience
- General Biochemistry, Genetics and Molecular Biology
- General Immunology and Microbiology